{
    "abstract": "Cesarean scar ectopic pregnancy (CSP) is a rare form of ectopic pregnancy, and treatment of CSP with uterine artery embolization (UAE) is a novel approach. With increasing numbers of cesarean sections being performed annually, the incidence of this condition is likely to increase. The authors became aware of an unusually high number of published studies originating in mainland China regarding this unusual treatment and sought to perform a meta-analysis to provide comprehensive evidence on this novel practice.\nWe performed a thorough search and included all forms of quality studies on this topic that reported UAE as a part of first-line management of CSP. We included only studies originating in China. Ultimately, 37 studies were included for qualitative and quantitative synthesis of evidence. After screening retrieved records and extracting data from eligible studies, we pooled continuous data as a mean estimate and 95% confidence interval (CI), and dichotomous data as proportion and 95% CI.\nCSP patients treated with protocols including UAE had a mean time of 30 days for serum \u03b2-hCG normalization, 95% CI [26.816, 33.881]. They had a mean estimated intraprocedural blood loss of 4.19 \u00b1 3.76 mL, a mean hospital stay of nine days, 95%CI [7.914, 9.876], and a success rate of 93.4%, 95%CI [0.918, 0.951]. The severe complication rate was 1.2%, 95%CI [0.008, 0.017].\nUAE, in combination with other procedures is being used effectively for the treatment of CSP in China. Protocols including UAE have a success rate of approximately 93.4%, and a severe complication rate of approximately 1.2%. This data's utility is limited by vast differences in the studied protocols and questionable feasibility outside of China.",
    "authors": [
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.",
            "firstname": "Greg J",
            "initials": "GJ",
            "lastname": "Marchand"
        },
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.\nFaculty of Medicine, Fayoum University, Fayoum 63514, Egypt.",
            "firstname": "Ahmed Taher",
            "initials": "AT",
            "lastname": "Masoud"
        },
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.",
            "firstname": "Catherine",
            "initials": "C",
            "lastname": "Coriell"
        },
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.",
            "firstname": "Hollie",
            "initials": "H",
            "lastname": "Ulibarri"
        },
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.",
            "firstname": "Julia",
            "initials": "J",
            "lastname": "Parise"
        },
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.",
            "firstname": "Amanda",
            "initials": "A",
            "lastname": "Arroyo"
        },
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.",
            "firstname": "Sydnee",
            "initials": "S",
            "lastname": "Goetz"
        },
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.",
            "firstname": "Carmen",
            "initials": "C",
            "lastname": "Moir"
        },
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.",
            "firstname": "Atley",
            "initials": "A",
            "lastname": "Moberly"
        },
        {
            "affiliation": "Marchand Institute for Minimally Invasive Surgery, Mesa, AZ 85209, USA.",
            "firstname": "Malini",
            "initials": "M",
            "lastname": "Govindan"
        }
    ],
    "conclusions": "UAE, in combination with other procedures is being used effectively for the treatment of CSP in China. Protocols including UAE have a success rate of approximately 93.4%, and a severe complication rate of approximately 1.2%. This data's utility is limited by vast differences in the studied protocols and questionable feasibility outside of China.",
    "copyrights": null,
    "doi": "10.3390/jcm11247393\n10.1016/S0733-8627(03)00036-1\n10.1080/13645700600771942\n10.1002/uog.56\n10.1016/S0140-6736(14)60716-9\n10.1002/14651858.CD004660.pub3\n10.7863/jum.2011.30.9.1179\n10.1002/uog.974\n10.1016/j.ijgo.2004.12.038\n10.1002/jcu.20374\n10.1097/01.AOG.0000218690.24494.ce\n10.1016/j.ijgo.2010.11.027\n10.1016/j.jvir.2012.08.013\n10.1016/j.ejogrb.2011.11.026\n10.1007/s00404-018-4686-8\n10.12659/MSM.907404\n10.1111/jog.14720\n10.1016/j.jclinepi.2009.06.006\n10.1097/MD.0000000000009584\n10.1016/j.ejogrb.2017.04.032\n10.4103/2096-2924.288024\n10.1159/000381263\n10.1016/S1001-7844(09)60020-1\n10.3389/fsurg.2020.00023\n10.2147/TCRM.S220852\n10.1016/j.ijgo.2014.05.005\n10.1097/MD.0000000000007687\n10.1111/jog.14258\n10.1002/ijgo.12636\n10.3109/00016349.2010.512973\n10.1007/s00404-017-4426-5\n10.1007/s00404-015-3952-2\n10.1016/j.tjog.2020.03.008\n10.1097/MD.0000000000007327\n10.1186/s12884-020-03062-z\n10.5114/wiitm.2020.100713\n10.1016/j.tjog.2015.01.003\n10.1007/s00404-015-3730-1\n10.2147/TCRM.S184387\n10.1016/j.ajog.2012.09.012\n10.1016/j.ejogrb.2019.08.004\n10.1007/s00270-018-1934-z\n10.1016/j.ijgo.2013.06.029\n10.4103/2096-2924.242751\n10.1097/MD.0000000000014913\n10.12891/ceog5013.2019\n10.1111/j.1471-0528.2010.02578.x\n10.3109/02656736.2015.1104733\n10.1016/j.ajog.2009.04.038\n10.1016/j.jmig.2016.08.819\n10.1186/s12958-020-00666-0\n10.3892/etm.2016.3489\n10.1111/jog.12051\n10.1016/j.fertnstert.2015.12.130",
    "journal": "Journal of clinical medicine",
    "keywords": [
        "cesarean scar",
        "ectopic pregnancy",
        "extrauterine pregnancy",
        "uterine artery embolization"
    ],
    "methods": null,
    "publication_date": "2022-12-24",
    "pubmed_id": "36556010\n12962347\n17062405\n12666214\n24766963\n16856054\n21876087\n15027012\n15847889\n17763455\n16738166\n21458810\n23177105\n22153905\n29497822\n29978852\n33749101\n19631507\n29538216\n24931250\n28472704\n25926054\n32671091\n31819464\n25212971\n25248928\n28746234\n25932203\n32307813\n30074243\n20726832\n28634752\n26581398\n32416884\n28640149\n32600442\n33786140\n26384053\n25935196\n30662266\n23107082\n31437622\n29546456\n24054055\n30882712\n20536432\n26644262\n19527897\n27553186\n33168010\n27602071\n23718134\n26794422",
    "results": "CSP patients treated with protocols including UAE had a mean time of 30 days for serum \u03b2-hCG normalization, 95% CI [26.816, 33.881]. They had a mean estimated intraprocedural blood loss of 4.19 \u00b1 3.76 mL, a mean hospital stay of nine days, 95%CI [7.914, 9.876], and a success rate of 93.4%, 95%CI [0.918, 0.951]. The severe complication rate was 1.2%, 95%CI [0.008, 0.017].",
    "title": "Treatment of Cesarean Scar Ectopic Pregnancy in China with Uterine Artery Embolization-A Systematic Review and Meta-Analysis.",
    "xml": "<Element 'PubmedArticle' at 0x788503964040>"
}